Allegis Capital
Edit

Allegis Capital

https://www.allegiscapital.com
Last activity: 22.06.2026
Active
Invests in categories: BusinessDataE-commerceFinTechInsurTechManagementPlatformSecuritySoftwareTechnology
Allegis Capital is a global early-stage venture capital firm that invests in fintech, enterprise software, and climate tech.
Followers
79
Portfolio
39
Persons
7
Mentions
68
Location: United States, California, Palo Alto
Employees: 1-10
Founded date: 1995
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series C

Portfolio 39

DateNameWebsiteTotal RaisedLocation
16.06.2026Attotude I...attotude.com$131MUnited Sta...
29.10.2025Polygrafpolygraf.ai$9.5MUnited Sta...
31.07.2025Ultromicsultromics.com$112.58MUnited Kin...
13.05.2024RYSErysemarket.com--
13.05.2024Pylonpylonlending.com$8.5MUnited Sta...
13.05.2024Honahona.ai--
09.02.2024Haddyhaddy.life-United Sta...
09.02.2024Lightshiplightshiprv.com$60.6MUnited Sta...
09.02.2024Steve Chennewretirement.com$20MUnited Sta...
09.02.2024healthOme,...healthome.com-United Sta...
Show more

Persons 7

DateFirst NameLast NameTitleLinkedInLocation
-stuart doa...--linkedin.c...-
-Jennifer S...--linkedin.c...-
-Ryan parke...--linkedin.c...-
-victor wes...--linkedin.c...-
-pete bodin...--linkedin.c...-
-Spencer ta...--linkedin.c...-
-TSUNEY Yan...--linkedin.c...-

Mentions in press and media 68

DateTitleDescription
22.06.2026Syntax Bio Raises $14.4 Million Series A And Announces Leadership AppointmentsSyntax Bio announced an expanded Series A round and several leadership appointments across its executive team, board of directors, and scientific advisory board. The expanded round brings Syntax Bio’s Series A to $14.4 million and total fun...
22.06.2026Syntax Bio Expands Series A to $14.4MSyntax Bio, a Chicago, IL-based synthetic biology company programming new cell therapies, expanded its Series A to $14.4M. The expanded round saw participation from Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Vent...
18.06.2026AttoTude Secures $52M Series C, Revolutionizing AI InterconnectsAttoTude secures $52 million Series C funding. This capital accelerates commercialization of its groundbreaking interconnect technology. The innovative "ASIC over Dielectric" platform redefines AI and hyperscale infrastructure. It...
16.06.2026AttoTude Raises $52 Million Series C To Accelerate AI Interconnect TechnologyAttoTude announced that it has raised $52 million in Series C funding to accelerate the commercialization of its interconnect technology designed for hyperscale and AI infrastructure. The financing round was led by The Westly Group and incl...
16.06.2026AttoTude Secures $52M in Series C FundingAttoTude Inc., a Menlo Park, CA-based company leveraging interconnect technology for AI infrastructure, raised $52M in Series C funding. The round was led by The Westly Group with participation from Keysight, Allegis Capital, DNX, Sutter Hi...
31.10.2025Polygraf AI Secures $9.5M Seed Funding for Enterprise AI SecurityPolygraf AI, an Austin-based leader in AI security, closed a $9.5 million seed funding round. Allegis Capital led the investment. The company's proprietary Small Language Models (SLMs) offer on-premise protection against deepfakes, fraud, a...
29.10.2025Polygraf AI: $9.5 Million Seed Funding Closed To Scale Enterprise AI Security SolutionsPolygraf AI, a Texas-based artificial intelligence security company, has raised $9.5 million in seed funding to accelerate its mission of securing enterprise and government AI ecosystems against threats such as deepfakes, data leaks, and AI...
29.10.2025Polygraf AI Closes $9.5M Seed FundingPolygraf AI, an Austin, Texas-based provider of an AI security platform for critical operations, closed a $9.5M seed funding round. The round was led by Allegis Capital and participation from Alumni Ventures, DataPower VC, Domino Ventures a...
31.07.2025Ultromics Secures $55M to Revolutionize Heart Disease Diagnosis with AIUltromics, a leader in AI-driven cardiology, secured $55 million in Series C funding. This significant investment propels its mission to transform heart disease diagnosis. The company's EchoGo® platform utilizes advanced AI. It analyzes sta...
31.07.2025Britain’s cardiology diagnostics solution Ultromics raises €48 million to detect elusive forms of heart failureOxford-based Ultromics, an innovator in AI-driven cardiology diagnostics solutions, today announced it has raised €48 million through its Series C funding round. The funding round was co-led by L&G, Allegis Capital, and Lightrock. It al...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In